Sign Up to like & get
recommendations!
0
Published in 2025 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.5c00066
Abstract: Provided herein are novel compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating mental illness or CNS disorders and processes for preparing such compounds.
read more here.
Keywords:
mental illness;
treating mental;
ht2a agonists;
compounds ht2a ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.5c00244
Abstract: Provided herein are novel pyridine derivatives as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychiatric disorders, and processes for preparing such compounds.
read more here.
Keywords:
psychiatric disorders;
ht2a agonists;
novel pyridine;
pyridine derivatives ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.5c00389
Abstract: Provided herein are novel compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating mental illness or CNS disorders, and processes for preparing such compounds.
read more here.
Keywords:
mental illness;
treating mental;
ht2a agonists;
compounds ht2a ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.5c00484
Abstract: Provided herein are novel serotonergic psychedelic agents as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders, and processes for preparing such compounds.
read more here.
Keywords:
agents ht2a;
psychedelic agents;
ht2a agonists;
treating psychosis ... See more keywords